Falls among middle-aged women in the Women's Interagency HIV Study

Anjali Sharma, Donald R. Hoover, Qiuhu Shi, Susan Holman, Michael W. Plankey, Amber L. Wheeler, Kathleen Weber, Michelle Floris-Moore, Hector H. Bolivar, David E. Vance, Wendy J. Mack, Elizabeth Golub, Marcia Mc Donnell Holstad, Michael T. Yin

Research output: Contribution to journalArticle

Abstract

Background: To determine the frequency and risk factors for falls among middle-aged HIV+ and HIV- women in the Women's Interagency HIV Study (WIHS). Methods: We quantified self-report of any and multiple (≥2) falls in the prior 6 months among 1,412 HIV+ and 650 HIV- women with mean age 48 years. Logistic regression was used to evaluate associations of demographics, behavioural factors, comorbid conditions and medications with odds of any fall (versus none) and multiple falls (versus ≤1 fall). Results: At least one fall was reported in 263 HIV+ (19%) versus 119 HIV- (18%) women, and ≥2 falls reported in 133 HIV+ (9%) versus 65 HIV- (10%) women. HIV infection was not associated with falls in multivariate analyses. Factors independently associated with any fall included age (adjusted odds ratio [aOR] 1.71, 95% CI 1.17, 2.49 age 50-59 versus <39 years; aOR 2.26, 95% CI 1.38, 3.71 age ≥60 versus <39), current marijuana use (aOR 2.19, 95% CI 1.53, 3.13) depressive symptoms (aOR 1.57, 95% CI 1.21, 2.05 for Center for Epidemiology Studies Depression score ≥16), subjective cognitive complaints (aOR 2.19, 95% CI 1.56, 3.08), neuropathy (aOR 1.59, 95% CI 1.19, 2.13), obesity (aOR 1.39, 95% CI 1.08, 1.80), number of central nervous system active agents (aOR 2.98, 95% CI 1.90, 4.68 for ≥3 agents versus 0) and WIHS site. Factors associated with ≥2 falls included age, marijuana use, number of central nervous system active agents, subjective cognitive complaints, depressive symptoms, neuropathy and study site. Conclusions: Falls were associated with factors affecting cognition, but not HIV status in this large cohort of women. Longitudinal studies are needed to determine the incidence and consequences of falls by HIV status as women age.

Original languageEnglish (US)
Pages (from-to)697-706
Number of pages10
JournalAntiviral Therapy
Volume21
Issue number8
DOIs
StatePublished - 2016

Fingerprint

HIV
Odds Ratio
Central Nervous System Agents
Cannabis
Depression
Women's Rights
Self Report
Cognition
HIV Infections
Longitudinal Studies
HIV-1
Epidemiology
Multivariate Analysis
Obesity
Logistic Models
Demography
Incidence

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Sharma, A., Hoover, D. R., Shi, Q., Holman, S., Plankey, M. W., Wheeler, A. L., ... Yin, M. T. (2016). Falls among middle-aged women in the Women's Interagency HIV Study. Antiviral Therapy, 21(8), 697-706. https://doi.org/10.3851/IMP3070

Falls among middle-aged women in the Women's Interagency HIV Study. / Sharma, Anjali; Hoover, Donald R.; Shi, Qiuhu; Holman, Susan; Plankey, Michael W.; Wheeler, Amber L.; Weber, Kathleen; Floris-Moore, Michelle; Bolivar, Hector H.; Vance, David E.; Mack, Wendy J.; Golub, Elizabeth; Holstad, Marcia Mc Donnell; Yin, Michael T.

In: Antiviral Therapy, Vol. 21, No. 8, 2016, p. 697-706.

Research output: Contribution to journalArticle

Sharma, A, Hoover, DR, Shi, Q, Holman, S, Plankey, MW, Wheeler, AL, Weber, K, Floris-Moore, M, Bolivar, HH, Vance, DE, Mack, WJ, Golub, E, Holstad, MMD & Yin, MT 2016, 'Falls among middle-aged women in the Women's Interagency HIV Study', Antiviral Therapy, vol. 21, no. 8, pp. 697-706. https://doi.org/10.3851/IMP3070
Sharma A, Hoover DR, Shi Q, Holman S, Plankey MW, Wheeler AL et al. Falls among middle-aged women in the Women's Interagency HIV Study. Antiviral Therapy. 2016;21(8):697-706. https://doi.org/10.3851/IMP3070
Sharma, Anjali ; Hoover, Donald R. ; Shi, Qiuhu ; Holman, Susan ; Plankey, Michael W. ; Wheeler, Amber L. ; Weber, Kathleen ; Floris-Moore, Michelle ; Bolivar, Hector H. ; Vance, David E. ; Mack, Wendy J. ; Golub, Elizabeth ; Holstad, Marcia Mc Donnell ; Yin, Michael T. / Falls among middle-aged women in the Women's Interagency HIV Study. In: Antiviral Therapy. 2016 ; Vol. 21, No. 8. pp. 697-706.
@article{b46df8738bdd4fe5b0dab7b6c55b01d9,
title = "Falls among middle-aged women in the Women's Interagency HIV Study",
abstract = "Background: To determine the frequency and risk factors for falls among middle-aged HIV+ and HIV- women in the Women's Interagency HIV Study (WIHS). Methods: We quantified self-report of any and multiple (≥2) falls in the prior 6 months among 1,412 HIV+ and 650 HIV- women with mean age 48 years. Logistic regression was used to evaluate associations of demographics, behavioural factors, comorbid conditions and medications with odds of any fall (versus none) and multiple falls (versus ≤1 fall). Results: At least one fall was reported in 263 HIV+ (19{\%}) versus 119 HIV- (18{\%}) women, and ≥2 falls reported in 133 HIV+ (9{\%}) versus 65 HIV- (10{\%}) women. HIV infection was not associated with falls in multivariate analyses. Factors independently associated with any fall included age (adjusted odds ratio [aOR] 1.71, 95{\%} CI 1.17, 2.49 age 50-59 versus <39 years; aOR 2.26, 95{\%} CI 1.38, 3.71 age ≥60 versus <39), current marijuana use (aOR 2.19, 95{\%} CI 1.53, 3.13) depressive symptoms (aOR 1.57, 95{\%} CI 1.21, 2.05 for Center for Epidemiology Studies Depression score ≥16), subjective cognitive complaints (aOR 2.19, 95{\%} CI 1.56, 3.08), neuropathy (aOR 1.59, 95{\%} CI 1.19, 2.13), obesity (aOR 1.39, 95{\%} CI 1.08, 1.80), number of central nervous system active agents (aOR 2.98, 95{\%} CI 1.90, 4.68 for ≥3 agents versus 0) and WIHS site. Factors associated with ≥2 falls included age, marijuana use, number of central nervous system active agents, subjective cognitive complaints, depressive symptoms, neuropathy and study site. Conclusions: Falls were associated with factors affecting cognition, but not HIV status in this large cohort of women. Longitudinal studies are needed to determine the incidence and consequences of falls by HIV status as women age.",
author = "Anjali Sharma and Hoover, {Donald R.} and Qiuhu Shi and Susan Holman and Plankey, {Michael W.} and Wheeler, {Amber L.} and Kathleen Weber and Michelle Floris-Moore and Bolivar, {Hector H.} and Vance, {David E.} and Mack, {Wendy J.} and Elizabeth Golub and Holstad, {Marcia Mc Donnell} and Yin, {Michael T.}",
year = "2016",
doi = "10.3851/IMP3070",
language = "English (US)",
volume = "21",
pages = "697--706",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "8",

}

TY - JOUR

T1 - Falls among middle-aged women in the Women's Interagency HIV Study

AU - Sharma, Anjali

AU - Hoover, Donald R.

AU - Shi, Qiuhu

AU - Holman, Susan

AU - Plankey, Michael W.

AU - Wheeler, Amber L.

AU - Weber, Kathleen

AU - Floris-Moore, Michelle

AU - Bolivar, Hector H.

AU - Vance, David E.

AU - Mack, Wendy J.

AU - Golub, Elizabeth

AU - Holstad, Marcia Mc Donnell

AU - Yin, Michael T.

PY - 2016

Y1 - 2016

N2 - Background: To determine the frequency and risk factors for falls among middle-aged HIV+ and HIV- women in the Women's Interagency HIV Study (WIHS). Methods: We quantified self-report of any and multiple (≥2) falls in the prior 6 months among 1,412 HIV+ and 650 HIV- women with mean age 48 years. Logistic regression was used to evaluate associations of demographics, behavioural factors, comorbid conditions and medications with odds of any fall (versus none) and multiple falls (versus ≤1 fall). Results: At least one fall was reported in 263 HIV+ (19%) versus 119 HIV- (18%) women, and ≥2 falls reported in 133 HIV+ (9%) versus 65 HIV- (10%) women. HIV infection was not associated with falls in multivariate analyses. Factors independently associated with any fall included age (adjusted odds ratio [aOR] 1.71, 95% CI 1.17, 2.49 age 50-59 versus <39 years; aOR 2.26, 95% CI 1.38, 3.71 age ≥60 versus <39), current marijuana use (aOR 2.19, 95% CI 1.53, 3.13) depressive symptoms (aOR 1.57, 95% CI 1.21, 2.05 for Center for Epidemiology Studies Depression score ≥16), subjective cognitive complaints (aOR 2.19, 95% CI 1.56, 3.08), neuropathy (aOR 1.59, 95% CI 1.19, 2.13), obesity (aOR 1.39, 95% CI 1.08, 1.80), number of central nervous system active agents (aOR 2.98, 95% CI 1.90, 4.68 for ≥3 agents versus 0) and WIHS site. Factors associated with ≥2 falls included age, marijuana use, number of central nervous system active agents, subjective cognitive complaints, depressive symptoms, neuropathy and study site. Conclusions: Falls were associated with factors affecting cognition, but not HIV status in this large cohort of women. Longitudinal studies are needed to determine the incidence and consequences of falls by HIV status as women age.

AB - Background: To determine the frequency and risk factors for falls among middle-aged HIV+ and HIV- women in the Women's Interagency HIV Study (WIHS). Methods: We quantified self-report of any and multiple (≥2) falls in the prior 6 months among 1,412 HIV+ and 650 HIV- women with mean age 48 years. Logistic regression was used to evaluate associations of demographics, behavioural factors, comorbid conditions and medications with odds of any fall (versus none) and multiple falls (versus ≤1 fall). Results: At least one fall was reported in 263 HIV+ (19%) versus 119 HIV- (18%) women, and ≥2 falls reported in 133 HIV+ (9%) versus 65 HIV- (10%) women. HIV infection was not associated with falls in multivariate analyses. Factors independently associated with any fall included age (adjusted odds ratio [aOR] 1.71, 95% CI 1.17, 2.49 age 50-59 versus <39 years; aOR 2.26, 95% CI 1.38, 3.71 age ≥60 versus <39), current marijuana use (aOR 2.19, 95% CI 1.53, 3.13) depressive symptoms (aOR 1.57, 95% CI 1.21, 2.05 for Center for Epidemiology Studies Depression score ≥16), subjective cognitive complaints (aOR 2.19, 95% CI 1.56, 3.08), neuropathy (aOR 1.59, 95% CI 1.19, 2.13), obesity (aOR 1.39, 95% CI 1.08, 1.80), number of central nervous system active agents (aOR 2.98, 95% CI 1.90, 4.68 for ≥3 agents versus 0) and WIHS site. Factors associated with ≥2 falls included age, marijuana use, number of central nervous system active agents, subjective cognitive complaints, depressive symptoms, neuropathy and study site. Conclusions: Falls were associated with factors affecting cognition, but not HIV status in this large cohort of women. Longitudinal studies are needed to determine the incidence and consequences of falls by HIV status as women age.

UR - http://www.scopus.com/inward/record.url?scp=85011311222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011311222&partnerID=8YFLogxK

U2 - 10.3851/IMP3070

DO - 10.3851/IMP3070

M3 - Article

VL - 21

SP - 697

EP - 706

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 8

ER -